Vulnerability Description
An improper access control vulnerability may allow privilege escalation.This issue affects: * ELI 380 Resting Electrocardiograph: Versions 2.6.0 and prior; * ELI 280/BUR280/MLBUR 280 Resting Electrocardiograph: Versions 2.3.1 and prior; * ELI 250c/BUR 250c Resting Electrocardiograph: Versions 2.1.2 and prior; * ELI 150c/BUR 150c/MLBUR 150c Resting Electrocardiograph: Versions 2.2.0 and prior.
CVSS Score
HIGH
Related Weaknesses (CWE)
References
- https://hillrom.com/en/responsible-disclosures/
- https://www.cisa.gov/news-events/ics-medical-advisories/icsma-22-167-01
FAQ
What is CVE-2022-26389?
CVE-2022-26389 is a vulnerability with a CVSS score of 7.7 (HIGH). An improper access control vulnerability may allow privilege escalation.This issue affects: * ELI 380 Resting Electrocardiograph: Versions 2.6.0 and prior; * ELI 280/BUR280/MLBUR 280 Resting...
How severe is CVE-2022-26389?
CVE-2022-26389 has been rated HIGH with a CVSS base score of 7.7/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2022-26389?
Check the references section above for vendor advisories and patch information. Review vendor security bulletins for remediation guidance.